Taken together, multiple lines of evidence indicate that activation/inhibition of PPARγ by natural or synthetic ligands exerts tumor modulating effects 32 and could therefore also be used to treat or prevent breast cancer surgery associated seroma development. The gene discussed is PPARG; the disease is breast cancer.